(Q36613922)

15 August 2017

1 reference

title

Management of sepsis in the critically ill patient: key aspects (English)

1 reference

15 August 2017

0 references

1

Jean-Louis Vincent

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Expert Opinion on Pharmacotherapy

15 August 2017

published in

1 reference

15 August 2017

volume

7

1 reference

15 August 2017

issue

15

1 reference

15 August 2017

page(s)

2037-2045

1 reference

Sepsis in European intensive care units: results of the SOAP study.

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The epidemiology of sepsis in the United States from 1979 through 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The pathophysiology and treatment of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Microcirculatory alterations in ischemia-reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Survival of patients with bacteraemia in relation to initial empirical antimicrobial treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Early goal-directed therapy in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

High tidal volume and positive fluid balance are associated with worse outcome in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Fluid challenge revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The effects of vasopressin on hemodynamics and renal function in severe septic shock: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Terlipressin for norepinephrine-resistant septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Terlipressin in catecholamine-resistant septic shock patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Clinical review: Vasopressin and terlipressin in septic shock patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Anemia and blood transfusion in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The CRIT Study: Anemia and blood transfusion in the critically ill--current clinical practice in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Clinical spectrum of mediastinal cysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Safety assessment of drotrecogin alfa (activated) in the treatment of adult patients with severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Activated protein C: do more survive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Use of an integrated clinical trial database to evaluate the effect of timing of drotrecogin alfa (activated) treatment in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Interobserver variability in data collection of the APACHE II score in teaching and community hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Intra-observer variability in APACHE II scoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Expression and function of the endothelial protein C receptor in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Clinical effectiveness and cost-effectiveness of drotrecogin alfa (activated) (Xigris) for the treatment of severe sepsis in adults: a systematic review and economic evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Local treatment pattern versus trial-based data: a cost-effectiveness analysis of drotrecogin alfa (activated) in the treatment of severe sepsis in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Give your patient a fast hug (at least) once a day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Intensive insulin therapy in the medical ICU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The relationship between labour cost per patient and the size of intensive care units: a multicentre prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

The last 100 years of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Has the mortality of septic shock changed with time

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

Sepsis change bundles: converting guidelines into meaningful change in behavior and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2037

10.1517/14656566.7.15.2037

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference